Montalbo, Rhea .

HRN: 19-24-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFOTAXIME 500MG (VIAL)
04/08/2025
04/15/2025
IV
480mg
Q8 Hours
Acute Bacterial Infection
Waiting Final Action 
04/08/2025
CEFUROXIME 750MG (VIAL)
04/08/2025
04/15/2025
IV
480mg
Q8h
Acute Bacterial Infection
Waiting Final Action 
04/10/2025
MUPIROCIN 2%, 15G (TUBE)
04/10/2025
04/16/2025
TOPICAL
2%
BID
Post Extraction Site Hematoma
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: